Italia markets closed

Illumina, Inc. (0J8Z.L)

LSE - LSE Prezzo differito. Valuta in USD.
Aggiungi a watchlist
210,22-2,43 (-1,14%)
Alla chiusura: 04:17PM GMT

Illumina, Inc.

5200 Illumina Way
San Diego, CA 92122
United States
858 202 4500
https://www.illumina.com

Settore/i
Settore
Impiegati a tempo pieno9.800

Figure dirigenziali chiave

NomeTitoloRetribuzioneEsercitateAnno di nascita
Mr. Francis A. deSouzaCEO & DirectorN/DN/D1971
Dr. Alexander Aravanis M.D., Ph.D.CTO & Head of Research and Product Devel.1,05MN/D1977
Mr. Charles E. DadswellSr. VP, Gen. Counsel & Sec.N/DN/D1959
Ms. Susan H. TousiChief Commercial Officer1,04MN/D1969
Stephanie CamposPresN/DN/DN/D
Dr. Joydeep Goswami M.B.A., Ph.D.Chief Strategy & Corp. Devel. Officer and Interim CFON/DN/D1971
Mr. Kevin Carl PegelsChief of Global OperationsN/DN/DN/D
Mr. Scott EricksenVP & Chief Accounting OfficerN/DN/D1972
Ms. Carissa RollinsChief Information OfficerN/DN/DN/D
Ms. Sallilyn SchwartzVP of Investor RelationsN/DN/DN/D
Gli importi risalgono al giorno 31 dicembre 2021 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in USD.

Descrizione

Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. The company provides instruments and consumables used in genetic analysis; and genotyping and sequencing services, instrument service contracts, and development and licensing agreements, as well as cancer detection testing services. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in various markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. The company was incorporated in 1998 and is based in San Diego, California.

Governance aziendale

L'ISS Governance QualityScore di Illumina, Inc. al 1 dicembre 2022 è 6. I criteri di valutazione fondamentali sono revisione: 1; Consiglio di Amministrazione: 2; diritti degli azionisti: 8; retribuzione: 9.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.